According to a study published recently in the journal Clinical Therapeutics, there is significant variations in medical marijuana use based on patients’ medical conditions. Researchers from the University of Southern California, Brandeis University, and Monash University in Australia analyzed data from over 16,000 patients who purchased medical cannabis from dispensaries in New York over a …
Category: Studies
Oct 07 2024
Study: Abnormal Cannabinoids Show Potent Antifungal Activity Against Candida Species
In a new study, scientists have uncovered a powerful new use for abnormal cannabinoid (AbnCBD) derivatives. These unique compounds, distinct from traditional cannabinoids, have shown remarkable effectiveness in combating drug-resistant Candida species, notes the study’s researchers. Published in Pharmacological Research, the study reveals how these derivatives not only inhibit fungal growth but also disrupt biofilm …
Oct 07 2024
Study: Cannabinoids Show “Promising Potential” in Cancer Treatment
Published in the journal Discover Oncology, a comprehensive review conducted by researchers from institutions in Pakistan, Portugal, Turkey, Saudi Arabia, and South Korea investigates the potential role of cannabinoids in cancer treatment. The collaboration includes the Pakistan National University of Sciences and Technology, the University of the Punjab, and The Islamia University of Bahawalpur, along …
Oct 02 2024
Study Says Nanotechnology Could Revolutionize Marijuana-Based Medicine
A new study published in the journal Recent Advances in Drug Delivery and Formulation suggests that nanotechnology could be key to overcoming the challenges of effectively administering cannabis-based medicines. Conducted by researchers from the University of Michigan and the University at Buffalo, the study explores how nanotechnology could improve the bioavailability, solubility, and targeted delivery …
Oct 01 2024
Study: Chronic CBD Treatment May Improve Cardiovascular Health
An important new study published in the Journal of Hypertension reveals that long-term treatment with cannabidiol (CBD) can significantly improve cardiovascular health in an animal model of renovascular hypertension. Conducted by researchers from the Federal University of Paraiba and São Paulo State University in Brazil, the study explores CBD’s potential to lower blood pressure, enhance …
Oct 01 2024
Study: Psilocybin Increases Optimistic Engagement in Animal Model, Showing Potential for Depression Treatment
A new study published in the journal Translational Psychiatry provide insights into how psilocybin, the active compound in “magic mushrooms”, could aid in the treatment of depression. “Psilocybin has shown promise as a novel pharmacological intervention for treatment of depression, where post-acute effects of psilocybin treatment have been associated with increased positive mood and decreased …
Sep 29 2024
Study: Single Dose of Psilocybin Shows Promise for Veterans with Treatment-Resistant Depression
A recent study by researchers at Stanford University School of Medicine and Massachusetts General Hospital has revealed promising results for veterans battling severe treatment-resistant depression (TRD). Published in the Journal of Affective Disorders and online ahead of print by the National Library of Medicine, the study is the first to examine how a single dose …
Sep 27 2024
Study: Cannabis Cream Reduces Chronic Kidney Disease-Related Itching in Hemodialysis Patients
A new double-blind, placebo-controlled trial published in Kidney Medicine found that a cannabis-containing cream significantly reduced itching in patients with chronic kidney disease (CKD) undergoing hemodialysis. The study, conducted by researchers from Thammasat University in Thailand, involved 60 participants, all experiencing moderate to severe CKD-associated pruritus. The participants were divided into two groups: one received …
Sep 26 2024
Study: Cannabistilbene I Shows Potential to Reduce Angiotensin II-Induced Cardiac Hypertrophy
A study published in the peer reviewed journal Cannabis and Cannabinoid Research and available online through the U.S. National Library of Medicine explores the effects of Cannabistilbene I (a compound found in cannabis) on Angiotensin II (Ang II)-induced cardiac hypertrophy. The research, conducted by a team at the University of Alberta, examined how Cannabistilbene I …
Sep 25 2024
Study: Psilocybin Experiences “Increase Mind Perception but Do Not Alter Atheist-Believer Status”, Johns Hopkins Study Shows
Researchers at Johns Hopkins University School of Medicine have conducted a longitudinal study exploring how psilocybin experiences impact people’s beliefs about mind perception and their spiritual or metaphysical views. Published recently in the Journal of Psychoactive Drugs, the study involved 657 participants who planned to have a psilocybin experience outside a clinical setting. Participants were …